Related references
Note: Only part of the references are listed.Structural characterization of the Z RING-eIF4E complex reveals a distinct mode of control for eIF4E
Laurent Volpon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin
Sarit Assouline et al.
BLOOD (2009)
Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells
Ke Dong et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Cancer Statistics, 2009
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
Expression of Eukaryotic Initiation Factor 4E Predicts Clinical Outcome in Patients With Mantle Cell Lymphoma Treated With Hyper-CVAD and Rituximab, Alternating With Rituximab, High-Dose Methotrexate, and Cytarabine
Kedar V. Inamdar et al.
CANCER (2009)
eIF4E Activation Is Commonly Elevated in Advanced Human Prostate Cancers and Significantly Related to Reduced Patient Survival
Jeremy R. Graff et al.
CANCER RESEARCH (2009)
Crystallization of eIF4E complexed with eIF4GI peptide and glycerol reveals distinct structural differences around the cap-binding site
Christopher J. Brown et al.
CELL CYCLE (2009)
Eukaryotic Initiation Factor-4E and Cyclin D1 Expression Associated with Patient Survival in Lung Cancer
Thaer Khoury et al.
CLINICAL LUNG CANCER (2009)
Eukaryotic Initiation Factors (eIF) 2α and 4E Expression, Localization, and Phosphorylation in Brain Tumors
Sonia Tejada et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2009)
Overexpression of eukaryotic initiation factor 4E (eIF4E) and its clinical significance in lung adenocarcinoma
Rui Wang et al.
LUNG CANCER (2009)
Understanding and Targeting the Eukaryotic Translation Initiation Factor eIF4E in Head and Neck Cancer
Biljana Culjkovic et al.
JOURNAL OF ONCOLOGY (2009)
A Prospective Trial on Initiation Factor 4E (eIF4E) Overexpression and Cancer Recurrence in Node-Negative Breast Cancer
Neal Holm et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Ribavirin targets eIF4E dependent Akt survival signaling
Keith Tan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Pondering the puzzle of PML (promyelocytic leukemia) nuclear bodies: Can we fit the pieces together using an RNA regulon?
Katherine L. B. Borden
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2008)
Expression of the translation initiation factors eIF-4E and eIF-2α is frequently increased in neoplastic cells of Hodgkin lymphoma
Igor B. Rosenwald et al.
HUMAN PATHOLOGY (2008)
The eIF4E RNA regulon promotes the Akt signaling pathway
Biljana Culjkovic et al.
JOURNAL OF CELL BIOLOGY (2008)
Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity
Jeremy R. Graff et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Ribavirin uptake by cultured human choriocarcinoma (BeWo) cells and Xenopus laevis oocytes expressing recombinant plasma membrane human nucleoside transporters
Takashi Yamamoto et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Controlling gene expression through RNA regulons - The role of the eukaryotic translation initiation factor eIF4E
Biljana Culjkovic et al.
CELL CYCLE (2007)
Viral determinants of resistance to treatment in patients with hepatitis C
Anette Wohnsland et al.
CLINICAL MICROBIOLOGY REVIEWS (2007)
eIF4E is a central node of an RNA regulon that governs cellular proliferation
Biljana Culjkovic et al.
JOURNAL OF CELL BIOLOGY (2006)
High eIF4E, VEGF, and microvessel density in stage I to III breast cancer
K Byrnes et al.
ANNALS OF SURGERY (2006)
The metabolism, pharmacokinetics and mechanisms of antiviral activity of ribavirin against hepatitis C virus
NM Dixit et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2006)
eIF4E as a marker for cervical neoplasia
J Matthews-Greer et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2005)
Further evidence that ribavirin interacts with eIF4E
A Kentsis et al.
RNA (2005)
eIF-4E expression is associated with histopathologic grades in cervical neoplasia
JW Lee et al.
HUMAN PATHOLOGY (2005)
Phosphorylation of ribavirin and viramidine by adenosine kinase and cytosolic 5′-nucleotidase II:: Implications for ribavirin metabolism in erythrocytes
JZ Wu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Growth inhibition of head and neck squamous carcinoma cells by small interfering RNAs targeting eIF4E or cyclin D1 alone or combined with cisplatin
N Oridate et al.
CANCER BIOLOGY & THERAPY (2005)
Eukaryotic translation initiation factor 4E activity is modulated by HOXA9 at multiple levels
I Topisirovic et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Expression of eukaryotic initiation factor 4E in gastric adenocarcinoma and its association with clinical outcome
CN Chen et al.
JOURNAL OF SURGICAL ONCOLOGY (2004)
Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy
HG Wendel et al.
NATURE (2004)
Global effect of PEG-IFN-α and ribavirin on gene expression in PBMC in vitro
MW Taylor et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2004)
Ribavirin suppresses eIF4E-mediated oncogenic transformation by physical mimicry of the 7-methyl guanosine mRNA cap
A Kentsis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Effects of the IMP-dehydrogenase inhibitor, Tiazofurin, in bcr-abl positive acute myelogenous leukemia -: Part II.: In vitro studies
DG Wright et al.
LEUKEMIA RESEARCH (2004)
Effects of the IMP-dehydrogenase inhibitor, Tiazofurin, in bcr-abl positive acute myelogenous leukemia -: Part I.: In vivo studies
K Malek et al.
LEUKEMIA RESEARCH (2004)
The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis
D Ruggero et al.
NATURE MEDICINE (2004)
Ribavirin or CpG DNA sequence-modulated dendritic cells decrease the IgE level and airway inflammation
DJ Chiang et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Pharmacokinetics and metabolism of [14C]viramidine in rats and cynomolgus monkeys
CC Lin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
The proline-rich homeodomain protein, PRH, is a tissue-specific inhibitor of elF4E-dependent cyclin D1 mRNA transport and growth
I Topisirovic et al.
EMBO JOURNAL (2003)
Translation factor eIF4E rescues cells from Myc-dependent apoptosis by inhibiting cytochrome c release
S Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Aberrant eukaryotic translation initiation factor 4E-dependent mRNA transport impedes hematopoietic differentiation and contributes to leukemogenesis
I Topisirovic et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Translational control and metastatic progression: Enhanced activity of the mRNA cap-binding protein eIF-4E selectively enhances translation of metastasis-related mRNAs
JR Graff et al.
CLINICAL & EXPERIMENTAL METASTASIS (2003)
Control of biochemical reactions through supramolecular RING domain self-assembly
A Kentsis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
A model for co-expression pattern analysis of genes implicated in angiogenesis and tumour cell invasion in cervical cancer
PO Van Trappen et al.
BRITISH JOURNAL OF CANCER (2002)
Prospective study of eukaryotic initiation factor 4E protein elevation and breast cancer outcome
BDL Li et al.
ANNALS OF SURGERY (2002)
The emerging roles of translation factor eIF4E in the nucleus
S Strudwick et al.
DIFFERENTIATION (2002)
Expression of eukaryotic translation initiation factors 4E and 2α correlates with the progression of thyroid carcinoma
ST Wang et al.
THYROID (2001)
The RING domains of the promyelocytic leukemia protein PML and the arenaviral protein Z repress translation by directly inhibiting translation initiation factor eIF4E
A Kentsis et al.
JOURNAL OF MOLECULAR BIOLOGY (2001)
PML RING suppresses oncogenic transformation by reducing the affinity of eIF4E for mRNA
N Cohen et al.
EMBO JOURNAL (2001)
Stabilization of eukaryotic initiation factor 4E binding to the mRNA 5′-cap by domains of eIF4G
T von der Haar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Inhibition of Myc-dependent apoptosis by eukaryotic translation initiation factor 4E requires cyclin D1
A Tan et al.
ONCOGENE (2000)
Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C
ME Cramp et al.
GASTROENTEROLOGY (2000)
Share Paper
